Preferential inhibition of human phosphodiesterase 4 by ibudilast

This publication has 36 references indexed in Scilit:

• Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis
  Multiple Sclerosis Journal, 2004
• Preferential Inhibition of T Helper 1, but Not T Helper 2, Cytokines in Vitro by L-826,141 [4-{2-(3,4-Bisdifluromethoxyphenyl)-2-{4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl}-3-methylpyridine-1-oxide], a Potent and Selective Phosphodiesterase 4 Inhibitor
  The Journal of Pharmacology and Experimental Therapeutics, 2004
• Antiinflammatory Effects of the Phosphodiesterase-4 Inhibitor Cilomilast (Ariflo) in Chronic Obstructive Pulmonary Disease
  American Journal of Respiratory and Critical Care Medicine, 2003
• Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling
  Journal of Biological Chemistry, 2003
• Cyclic AMP-Mediated Inhibition of 5-Lipoxygenase Translocation and Leukotriene Biosynthesis in Human Neutrophils
  Molecular Pharmacology, 2002
• Allergic and immunologic disorders of the eye. Part II: Ocular allergy
  Journal of Allergy and Clinical Immunology, 2000
• Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes
  European Journal of Pharmacology, 1999
• The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor‐α and leukotriene B₄ in a novel human whole blood assay
  British Journal of Pharmacology, 1999
• Phosphodiesterase type 4 inhibitors, but not glucocorticoids, are more potent in suppression of cytokine secretion by mononuclear cells from atopic than nonatopic donors☆☆☆★
  Journal of Allergy and Clinical Immunology, 1998
• Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis
  British Journal of Pharmacology, 1995